Literature DB >> 21565979

Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21.

Naoto Tsuchiya1, Masashi Izumiya, Hiroko Ogata-Kawata, Koji Okamoto, Yuko Fujiwara, Makiko Nakai, Atsushi Okabe, Aaron J Schetter, Elise D Bowman, Yutaka Midorikawa, Yasuyuki Sugiyama, Hiroyuki Aburatani, Curtis C Harris, Hitoshi Nakagama.   

Abstract

Selective activation of p53 target genes in response to various cellular stresses is a critical step in determining the ability to induce cell-cycle arrest or apoptosis. Here we report the identification of the microRNA miR-22 as a p53 target gene that selectively determines the induction of p53-dependent apoptosis by repressing p21. Combinatorial analyses of the AGO2 immunocomplex and gene expression profiles identified p21 as a direct target of miR-22. Induction of p21 was inhibited by miR-22 after exposure to the genotoxic agent Adriamycin (doxorubicin; Bedford Laboratories), sensitizing cells to p53-dependent apoptosis. Interestingly, the activation of miR-22 depended on the intensity of the stresses that induced cells to undergo apoptosis in the presence of p21 suppression. Our findings define an intrinsic molecular switch that determines p53-dependent cellular fate through post-transcriptional regulation of p21. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565979      PMCID: PMC7425979          DOI: 10.1158/0008-5472.CAN-10-2475

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 2.  The p53 pathway: positive and negative feedback loops.

Authors:  Sandra L Harris; Arnold J Levine
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

Review 3.  microRNA target predictions in animals.

Authors:  Nikolaus Rajewsky
Journal:  Nat Genet       Date:  2006-06       Impact factor: 38.330

Review 4.  Histone H3 Lys 4 methylation: caught in a bind?

Authors:  Robert J Sims; Danny Reinberg
Journal:  Genes Dev       Date:  2006-10-15       Impact factor: 11.361

5.  Micro RNAs in animal development.

Authors:  Ronald H A Plasterk
Journal:  Cell       Date:  2006-03-10       Impact factor: 41.582

Review 6.  Small non-coding RNAs in animal development.

Authors:  Giovanni Stefani; Frank J Slack
Journal:  Nat Rev Mol Cell Biol       Date:  2008-03       Impact factor: 94.444

7.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

8.  Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers.

Authors:  H Konishi; T Takahashi; K Kozaki; Y Yatabe; T Mitsudomi; Y Fujii; T Sugiura; H Matsuda; T Takahashi; T Takahashi
Journal:  Oncogene       Date:  1998-10-22       Impact factor: 9.867

9.  Modulation of microRNA processing by p53.

Authors:  Hiroshi I Suzuki; Kaoru Yamagata; Koichi Sugimoto; Takashi Iwamoto; Shigeaki Kato; Kohei Miyazono
Journal:  Nature       Date:  2009-07-23       Impact factor: 49.962

10.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

View more
  63 in total

1.  MicroRNA-22 promotes cell survival upon UV radiation by repressing PTEN.

Authors:  Guangyun Tan; Yuling Shi; Zhao-Hui Wu
Journal:  Biochem Biophys Res Commun       Date:  2011-12-07       Impact factor: 3.575

Review 2.  MicroRNAs in colorectal cancer as markers and targets: Recent advances.

Authors:  Jing-Jia Ye; Jiang Cao
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 3.  Targeting CSC-related miRNAs for cancer therapy by natural agents.

Authors:  Bin Bao; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Ginny Bao; Shadan Ali; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

4.  miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver.

Authors:  Koji Okamoto; Tatsuya Ishiguro; Yutaka Midorikawa; Hirokazu Ohata; Masashi Izumiya; Naoto Tsuchiya; Ai Sato; Hiroaki Sakai; Hitoshi Nakagama
Journal:  EMBO J       Date:  2012-02-28       Impact factor: 11.598

5.  Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells.

Authors:  C Koufaris; G N Valbuena; Y Pomyen; G D Tredwell; E Nevedomskaya; C-He Lau; T Yang; A Benito; J K Ellis; H C Keun
Journal:  Oncogene       Date:  2015-10-19       Impact factor: 9.867

6.  The DEAD-box RNA helicase DDX41 is a novel repressor of p21WAF1/CIP1 mRNA translation.

Authors:  Dominik Peters; Claudia Radine; Alina Reese; Wilfried Budach; Dennis Sohn; Reiner U Jänicke
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

7.  The impact of microRNA expression on cellular proliferation.

Authors:  Divya Lenkala; Bonnie LaCroix; Eric R Gamazon; Paul Geeleher; Hae Kyung Im; R Stephanie Huang
Journal:  Hum Genet       Date:  2014-03-08       Impact factor: 4.132

8.  Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma.

Authors:  Francesca Bersani; Marcello Francesco Lingua; Deborah Morena; Valentina Foglizzo; Silvia Miretti; Letizia Lanzetti; Giovanna Carrà; Alessandro Morotti; Ugo Ala; Paolo Provero; Roberto Chiarle; Samuel Singer; Marc Ladanyi; Thomas Tuschl; Carola Ponzetto; Riccardo Taulli
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

9.  miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1.

Authors:  Mei-Mei Guo; Li-Hua Hu; Yong-Qiang Wang; Peng Chen; Jian-Guo Huang; Ning Lu; Jiang-Hong He; Cheng-Gong Liao
Journal:  Med Oncol       Date:  2013-03-26       Impact factor: 3.064

10.  Effect of human papillomavirus 16 oncoproteins on oncostatin M upregulation in oral squamous cell carcinoma.

Authors:  Jureeporn Chuerduangphui; Chamsai Pientong; Ponlatham Chaiyarit; Natcha Patarapadungkit; Apinya Chotiyano; Bunkerd Kongyingyoes; Supannee Promthet; Piyawut Swangphon; Weerayut Wongjampa; Tipaya Ekalaksananan
Journal:  Med Oncol       Date:  2016-06-27       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.